PAVE – Is PAVE’s Outperformance Set To Continue?

Author’s note: This article was released to CEF/ETF Income Laboratory members on May 10th.

The Global X U.S. Infrastructure Development ETF (BATS:PAVE) has performed exceedingly well these past few years, with twice the returns of the S&P 500 since mid-2020. PAVE’s outstanding performance was driven by its cheap valuation and strong growth prospects. Both of these have worsened in the recent past, although both remain at reasonable levels. In my opinion, PAVE remains a reasonable investment opportunity, but as fundamentals have worsened, I no longer expect the fund to outperform.

PAVE – Quick Overview

PAVE is an equity index ETF, investing in U.S. companies focusing on the development of U.S. infrastructure. The fund tracks the INDXX U.S. INFRASTRUCTURE DEVELOPMENT INDEX, an index of these same securities. The said index includes all U.S. equities from the following four industry segments / themes:

• Construction & Engineering Services.
• Raw Materials and Composites.
• Products and Equipment.
• Industrial Transportation.

Companies which derive the majority of their revenues from the above themes are eligible for inclusion in the index, although final security selection is somewhat discretionary.

PAVE focuses on infrastructure development companies, which mostly means industrials and materials. Industry exposures are as follows:

PAVE’s holdings themselves are reasonably well-diversified, with investments in 98 securities. The largest of these are as follows.

In prior articles, I’ve argued that PAVE’s investment thesis rests on the fund’s cheap valuation and strong growth prospects. These have both worsened in the recent past, casting doubt on the fund’s investment thesis. Let’s have a closer look at these developments.

PAVE – Worsening Fundamentals and Investment Thesis

Valuation Analysis

PAVE currently trades with a moderately cheaper valuation than the average U.S. equity or U.S. equity fund.

Importantly, PAVE should trade with a cheaper valuation than average, as the fund focuses on older, stodgier industries and companies with weaker growth prospects. A sufficiently large discount might indicate a market inefficiency or profit opportunity, while a small discount would simply indicate a fair, rational market value. PAVE’s current discount seems to be closer to the latter.

Specifically, as per J.P. Morgan, large-cap value stocks, the closest equity market segment to PAVE, are currently slightly overvalued relative to their historical averages. PAVE’s valuation is quite cheap, but is within normal, historical parameters for the market.

Industrials and materials, PAVE’s largest industries, look moderately overvalued relative to their historical averages, adding more weight to the above.

On a more positive note, value stocks look quite cheap relative to growth stocks right now, although less so than in prior months. Meaning, PAVE might not look all that cheap relative to its historical averages, but it does look cheap relative to tech, biotech, and other growth companies or industry niches.

In my opinion, it would be fair to characterize PAVE’s valuation as reasonable. It is a bit cheaper than the equity market average, much cheaper than growth stocks, but slightly more expensive than its own historical average. PAVE’s price and valuation seem fine, even slightly good, but I’m not seeing the potential for significant capital gains here. PAVE does not seem cheap enough for that.

Growth Prospects Analysis

PAVE’s underlying holdings have seen very strong growth these past few years. As per my calculations, these have averaged around 20.0% per year, with some volatility, and without accounting for changes in the fund’s portfolio. Growth was due to increased infrastructure spending, tariffs on foreign manufacturers, rebounding durable goods spending following the pandemic, and higher profit margins from skyrocketing demand.

Growth prospects seem to be weakening, however. ISM PMI, a U.S. economic barometer based on purchasing manager surveys, has steadily declined since mid-2021. It breached 50, indicating a generalized economic / manufacturing slowdown, in November 2022, and has remained there ever since.

Durables goods spending is stagnating, due to inflation, and as conditions normalize following the pandemic plus pandemic recovery.

Similar situation for manufacturing.

Profit margins are softening, due to weakening consumer demand, and as past supply chain issues are resolved.

PAVE’s declining earnings are also noticeable in the fund’s PE ratio. The said ratio has increased during the past year:

Even as the fund’s share price declines:

Depending on when, exactly, those PE ratios were calculated changes implied earnings growth rates, but these remain exceedingly weak regardless.

On a more positive note, analysts seem to be expecting reasonably strong 11.6% earnings growth for industrials, PAVE’s largest industry. Expected growth is quite high, albeit a bit lower than in the recent past. Analysts expect materials, the fund’s second-largest industry, to see earnings decline 10.5% next year.

From the above, it seems that PAVE’s growth prospects have weakened, although analyst expectations of these remain strong. Perhaps analysts have a more complete, accurate view of the situation than I do, or perhaps they have yet to update their figures.

In my opinion, PAVE’s growth prospects have significantly weakened these past few months. Growth expectations do remain strong, so perhaps the situation will improve in the coming months, but I’m seeing weakened fundamentals right now.

As with the fund’s valuation, growth prospects are such that the fund remains a reasonable investment opportunity, but I’m not seeing the potential for significant gains or outperformance here.

Conclusion

PAVE’s investment thesis rests on the fund’s cheap valuation and strong growth prospects. Both have weakened as of late, but remain at reasonable levels. As such, the fund is currently a reasonable investment, but not one which I believe has the potential for significant outperformance.